This Perspective describes the diagnosticlandscape for breast cancer management, molecular strategies targetingreceptors overexpressed in tumors, the theranostic potential of theoxytocin receptor (OTR) as an emerging breast cancer target, and thedevelopment of OTR-specific optical and nuclear tracers to study,visualize, and treat tumors. This evidence concerns the gene OXTR and breast carcinoma.